Ahn, S., Lee, M., Baek, Y., & Lee, S. (2022). A Randomized Pharmacokinetic Study in Healthy Male Subjects Comparing a High-concentration, Citrate-free SB5 Formulation (40 mg/0.4 ml) and Prior SB5 (Adalimumab Biosimilar). Rheumatology and therapy., 9(4), 1157-1169. https://doi.org/10.1007/s40744-022-00471-8
Chicago Style (17th ed.) CitationAhn, So-shin, Minkyung Lee, Yumin Baek, and Sukho Lee. "A Randomized Pharmacokinetic Study in Healthy Male Subjects Comparing a High-concentration, Citrate-free SB5 Formulation (40 mg/0.4 ml) and Prior SB5 (Adalimumab Biosimilar)." Rheumatology and Therapy. 9, no. 4 (2022): 1157-1169. https://doi.org/10.1007/s40744-022-00471-8.
MLA (9th ed.) CitationAhn, So-shin, et al. "A Randomized Pharmacokinetic Study in Healthy Male Subjects Comparing a High-concentration, Citrate-free SB5 Formulation (40 mg/0.4 ml) and Prior SB5 (Adalimumab Biosimilar)." Rheumatology and Therapy., vol. 9, no. 4, 2022, pp. 1157-1169, https://doi.org/10.1007/s40744-022-00471-8.